Daily - Go to TTD's     Chart scroller of  Breakout Stocks    - Monday - January 4, 2021

{short description of image}

Daily - Bullish Investors  - Go To TTD Pre-Market Opening Breakout Watch  List  - Monday - January 4, 2021

Daily - Bullish Aggressive Investor - Go To TTD Quick Trade Setups (74% win rate) - Monday - January 4, 2021

Go To Prior Days TTD "Reports"

Go to Video Show - "How to Make Money With Breakout Stocks

{short description of image}

Ticker Tape Digest

Monday - January 4, 2021

By Leo Fasciocco -- TTD

   Ticker Tape Digest presents its daily stock market report containing stocks to go long as Breakout Trades, Quick Trades, or Bargain Accumulation Trades.

  We also feature stocks under Significant Accumulation that are poised to breakout.

Ticker Tape Digest's

Daily schedule guide for TTD subscribers

1. Pre-market - check Breakout Watch List and Quick Trades.

2. Morning - (11:30 - 12 A.M.) - check breakout stocks tape and breakout chart slide show.

3. Midday (1 P.M.) check TTD Midsession Report and see market video show.

4. After close (4 P.M.) check final TTD Report for day.

Trading Strategies


Aggressive Investors Bullish - "Breakout Stocks" - ideally suited for bull markets and special situation stocks. Potential for large returns. (See Performance)

Aggressive Investor Bullish-  "Quick Trade Stocks" -ideally suited for entry into top performing issues looking for a small quick profit."  (See Performance)

Conservative Investors  "Bargain Buy Trades for the Long Term."  Ideally suited for entry into top performing big cap stocks on pullbacks within overall up trend.(See Performance)


Aggressive Bearish Investors - "Breakdown Stocks" to Sell Short. Ideally suited for bear markets or market pull backs. Potential for large returns  (See Performance)

   The TTD report also contains stocks to short as  breakdown plays and as bargain (swing trade) shorts.

  Investors should  tend to try to go with a strategy that fits with the stock market's trend, unless there is a special situation play.

  TTD's Breakout Stocks - Long are most suitable for aggressive investors seeking ideal entry points into leading stocks, especially during bull markets. They can do extremely well in bull markets with gains of as much as several hundred percent.

 These stocks can also do extremely well during strong market rallies, or if they are in a industry group that is performing very well. They tend to have strong earnings outlooks and are near new-52 week, or all-time highs.

  TTD Quick Trade Stocks - Long These are leading issues that have pulled back in recent days, but could move higher soon. They are most suitable for Aggressive Investors willing to trade short term. These stocks will do extremely  well during market advances. They have about 74% win rate. During market rally sequences the win rate is even higher. The return is small 3% to 8% in just a few days.

   TTD also presents Stocks To Sell or Sell Short. These issues are suitable for aggressive investors willing to take short positions both as trades or for longer-term plays. These stocks will do very well during bear markets or market pull backs.

  TTD's Bearish breakdown stocks to sell short. These issues have potential to fall sharply. They often show a technical breakdown and also some fundamental business problem such as weak earnings.  

 TTD's multi-media updates include a slide-show that presents charts and analysis at midsession. Some times TTD presents feature analysis on stocks and the market. TTD uses Windows Media Files. (WMV).

 TTD also presents a "Breakout Watch List" that is up dated daily. This list consists of key stocks in position to breakout. A close watch of this list can put you in the stock just as it breaks out. A good idea is to study the list and be ready to move into a stock quickly as it hits its breakpoint.

TTD often suggests using stop buy orders to enter. It is very important to buy a breakout stock as close as possible to the breakpoint. The idea is to get "elbow room" if the stock should follow through to the upside. This is very important in being successful in making big money with breakout stocks.

It is also essential to have a stop loss strategy for all stocks in which positions are taken. Not every stock will work as expected. It is important for investors to "police" their portfolios and avoid getting trapped in any bad positions.

 Quality rating of breakout  Two key factors: 1 - Stock near all-time high in price or near a 52-week high. 2 - earnings growth current year is strong. The ideal play is a stock with an Above Average Quality Rating. The stock is near a new high and will have strong earnings. TTD's other ratings are Average and Below Average.

Quote or chart

   TTD also has  special feature sections on  Educational Tips on Investing.

   To email Mr. Leo Fasciocco  leo@tickertapedigest.com.   

   For service, email Beverly Owen owen@tickertapedigest.com. TTD’s Tel: 1-480-878-8381 or 480-704-3331.

Monday - January 4, 2021

TTD's Breakout Stocks

  Stock Market Overview

Total Buy Breakouts   -  4

Quality of Breakouts -  Average.

Stocks Screened - 12,234

Bull side -  Small list of breakouts as stock market falls sharply.

Stock market  -  Major averages still hold bullish in all time sectors.

Comment -  Stock market falls sharply and momentum has turned to the downside. Bulls be conservative and watchful.  Earnings season now coming up.

See Latest Earnings Reports -  A company that tops the Street's highest earnings estimate has potential to go higher. Key earnings beats -  JEF

Stock Market Momentum

(Daily is based on a moving average)

Market (Daily)

 Market (Weekly)

 Market (Monthly)  

 Dow - Bullish

 Dow - Bullish

 Dow - Bullish

  Nasdaq - Bullish

  Nasdaq - Bullish

Nasdaq - Bullish

   S&P 500 - Bullish

  S&P 500 - Bullish

  S&P 500 - Bullish

Ticker Tape Digest's

Timely Breakout Stocks From Tape Action

(The “breakout List” gives all stocks breaking out of a base of five weeks or more. These stocks have a good chance to trend higher. However, a stop should be used to avoid those that do not work.

They are ranked according to percentage change and classified as leaders or other.

(Trading strategy: One should buy breakout stocks near breakpoint by using market order or stop buy.  They can also be bought soon after a follow through move, sometimes on an intraday pullback. )  

Today's Featured TTD Breakout Stock

Fulgent Genetics Inc. (FLGT) - 59.30, up 7.20 - Breakpoint 52.45

Net To Soar for 2020, TTD Targets 82

      TTD's Quality Rating of Stock - FLGT - ABOVE AVERAGE

  FLGT, based in Temple City, Ca., provides genetic testing and is involved in the corona virus work. Annual revenues: $32.5 million. FLGT's stock drives higher Monday and breaks out from its 5-week, flat base.

  So far today, FLGT is trading 4 million shares, double its average daily volume of 2 million shares.

  TTD sees potential for more on the upside.

  In after-hours trading, FLGT was up $1.10 a share.

  FLGT's stock moved higher in the morning and cleared its breakpoint line.

  The stock reached a peak at $59.10 in the morning.

  FLGT then pulled back to $55.

  However, the stock came on strong in the afternoon to close near its high for the day. That is bullish.

 Tape Action

  FLGT's tape action shows the recent block trades.

  One can see the price for the blocks climbing from $52.210 in the prior session to as high as $59.30 near the close.

  A key bullish trade came in the morning when a block of 54,049 shares (duplicated) crossed the tape at $54.88.

  That was up from the prior block in the prior session at $52.10 on 189,458 shares.   

  Near the close Monday a block of 44,431 shares (duplicated) crossed at $59.30.

  That was up from the prior block at $57.82 on 8,100 shares.


 FLGT offers genetic testing to provide physicians with clinically actionable diagnostic information.

  The company has been involved in corona virus testing.

The company developed a tech platform that integrates data comparison and suppression algorithms, adaptive learning software, advanced genetic diagnostics and integrated laboratory processes.

 FLGT's test menu includes  18,000 single-gene tests and over 200 pre-established, multi-gene, disease-specific panels that collectively test for some 7,500 genetic conditions, including various cancers, cardiovascular diseases and neurological disorders.  


  FLGT's 12-month performance chart shows the stock up 360% versus a 15% gain for the stock market.

  Insiders were recent buyers at 38 cents a share to $12.

  They were sellers at $15 to $51 a share.

  FLGT's long-term chart shows the stock coming public in 2016 at $9.30 a share.

  The stock pulled back to around $2 a share, lifted slightly and trended sideways. Last year, with the virus situation the stock took off and then surged higher steadily. It is now at a new all-time high at $59 - a fantastic move.

  FLGT's daily chart shows the stock climbing from $31 in November to $52.

  The stock put down a short flat base and now breaks out with a good expansion in volume.

  The stock had a strong move in the prior session.

  The breakout comes with a good widening of the daily spread.

  The stock's CCI momentum indicator is strongly bullish.

   Earnings Outlook

  Net for 2020 should surge to $4.35 a share from the 19 cents the prior year.

  Going out to 2021, the Street sees net hitting $5.70 a share, a 31% increase from  the anticipated $4.35 for 2020.

 Net for the fourth quarter should come in at $2.13 a share versus 4 cents the prior year.

  Then in the first quarter of 2021, analysts expect a profit of $2.13 a share against a loss of 3 cents the year before.

Strategy Opinion:  TTD is targeting FLGT for a move to $82 within the next few months, or sooner.

A protective stop can be placed near $52.

Intermediate-Term Rating: Average.

Suitability:   Aggressive Bulls.

                                 TTD's special research of Stock's Prior Performance:  

Breakout Success


  FLGT scored big gains off recent breakouts.

Response to Net


  FLGT rose 5 times after 11 earnings reports.

Seasonal Success


  FLGT avg. gain 11.6% in Jan., 4.5% in Feb. prior years.

Earnings Beats


  FLGT beat Street net estimate 5 times after 8 reports.

           Stock's Prior Performance After A Breakout

Stock's % Change from Breakout to peak - prior  to cut below 50-day M/A.

Date of Breakout

Break point Price

Stocks Price Peak after Breakout - prior to cut below 50-day M/A

  Date Trade Closed


   12/8/2020      48.57        51.08    12/10/2020


   7/27/2020      20.29        50.51    8/19/2020


   2/6/2020      15.69        19.75    2/18/2020


   8/2/2019        7.02        12.81    8/22/2019

(In actual trading, entry and exit points could vary depending on broker execution.

Also, ideal are breakouts to a new 52-week high or better, perhaps all-time highs.)

  Stock's Long-term Chart

   Stock's Price Performance after Reporting Earnings


 Stock's Performance Chart with Quarterly Earnings Markers vs. S&P 500

Insider Buying in Green  -  Insider Selling in Red

Charts of Selected Breakout Stocks

      TTD's Quality Rating of Stock - GSHD - ABOVE  AVERAGE

      TTD's Quality Rating of Stock - ROCK -  AVERAGE

      TTD's Quality Rating of Stock - BEP -  BELOW  AVERAGE


Ticker Tape Digest’s

Stocks To “Sell or Short”

    Ticker Tape Digest’s Daily List of “Stocks To Sell or Sell Short” ranks stocks well timed to be sold immediately based on daily trading. The list can be used as an alert to reduce current long-term positions.

Shorts from tape action  - 5

Stocks Screened - 12,234

Long-Term Environment for bears: Unfavorable.

Bear Side -  Small list of shorts. Chinese stocks down on possible delisting due to refusal to disclose financial information. Bears be conservative even though stock market now pulling back.

List of Stocks To Sell or Short

TTD’s Feature Bear Play

Calithera Biosciences Inc. (CALA) - 2.72

Loss Seen This Year and Next, TTD Sees Drop to 2

  CALA, based in South San Francisco, is a biotech firm working on treatments for tumors. Annual revenues: Nil. CALA's stock falls sharply Monday after one of the company's drugs failed testing.

  So far today, CALA is trading a heavy 16 million shares, 15 times its average daily volume of 1.1 million shares.

  TTD sees more on the downside even though the stock is low priced.

  TTD highlighted CALA as a short at our midsession video show on the Web Monday.

  The company said the combination of telsglenastat and cabozantinib did not meet the test of improving survival.

  CALA's stock fell sharply in the morning and undercut key technical support.

  The stock touched an intraday low of $2.46 in the morning.

  It lifted to around $2.70 and then trended sideways the rest of the day.

  In after hours trading, CALA was down 2 cents a share.

   Tape Action

  CALA's tape action shows the recent block trades.

  One can see the price for the blocks falling from $3.09 in the morning to as low as $2.75 later in the morning.

  A key bearish trade came in the morning when a block of 26,200 shares crossed at $2.98.

  That was down from the prior block at $3 on 20,879 shares.


 CALA is working with small molecule drugs directed against tumor and immune cell targets that control key metabolic pathways in the tumor microenvironment.

  It is developing agents that take advantage of the metabolic requirements of tumor cells and cancer-fighting immune cells, such as cytotoxic T-cells.

 The company's lead product candidate, CB-839, is a critical enzyme in tumor cells. Its other product candidate, CB-1158, is being developed for hematology and oncology.


  For 2020, the Street predicts a loss of $1.31 a share compared with a loss of $1.90 the prior year.

  Looking out to 2021, the Street predicts a loss of $1.17 a share.


  CALA's daily chart shows the stock plunging 44% down to $2.72 a share on heavy volume.

  The move undercuts key support. Although the stock is extended near-term, the downside momentum is strong.

Strategy Opinion: TTD  is targeting CALA for a decline to $2 within the next few months, or sooner. A protective stop buy can be placed near $3.10

Suitability:  Aggressive Bears.

  TTD's Stock Probability research of Prior Performance:  

Response to Net


 CALA rose 7 times after 15 earnings reports.

Seasonal Success


 CALA rose avg 16% in Jan., 14% in Feb. prior years.

Earnings Beats


 CALA beat Street estimate 3 times after 10 reports.

   TTD's Quality Rating of Stock  - CALA -  BELOW AVERAGE

   Stock's Performance Chart with Quarterly Earnings Markers vs. S&P 500

Insider Buying in Green  - Insider Selling in Red


   TTD takes no responsibility for trading by those using this information. The stocks presented in our report are those we deem the best looking "Day Trades" for the long side. We take no responsibility for the accuracy of this data, although every effort is made to present the information correctly. Copyright Ticker Tape Digest. - 2020

    TTD columnist Leo Fasciocco has covered the stock market for over 30 years. His articles appear in many publications. He has also been  a speaker at the Money Show conferences. He has been on television and radio. He is author of many educational articles about stock investing and the book “Guide To High-Performance Investing.”

{short description of image}

   For information to subscribe to the Ticker Tape Digest Services call: Beverly Owen at 1-480-878-8381.

   Distributed by Corona Publishing Enterprises. TickerTape Digest Inc. 1220 W. Sherri, Gilbert, Az. 85233.

  TTD “Professional Report” is available on the Web: $100 per month. Password needed. Published daily - around 20 times a month.  

 TTD Pro Report includes a Morning chart slide show of breakout stocks, a Midsession video-audio show with commentary on breakout stocks and shorts and a Final end of day overall report on breakout stocks for the session, short plays and accumulation plays.  There are other features too such as Quick Trades and Long-term Plays.  

TTD Daily Report is $39. It covers a Morning slide show of charts of stocks breaking out and a TTD end of day print report covering breakout stocks and shorts.

 Credit cards accepted. Payable to Corona Publishing Enterprises.

(The information contained has been prepared from data deemed reliable but there is no guarantee of complete accuracy. Ticker Tape Digest Inc. is not affiliated with any broker, dealer or investment advisor. Nothing in this publication constitutes an offer, recommendation or solicitation to buy or sell any securities. Further research is advised. This report is copyrighted and no redistribution is permitted with out permission.)